A decision tree for the use of estrogen replacement therapy or hormone replacement therapy in postmenopausal women: Consensus opinion of The North American Menopause Society

Wulf H. Utian, Margery L S Gass, Jay M. Sullivan, Glen D. Stettin, John Christopher G. Gallagher, Bruce Ettinger, Sandra Lewis

Research output: Contribution to journalReview article

46 Citations (Scopus)

Abstract

Objective: Menopause is associated with physiologic changes that may have negative effects on quality of life in some women and/or that may increase morbidity and mortality secondary to osteoporosis and/or coronary heart disease. Estrogen replacement therapy (ERT) and combined estrogen/progestogen therapy (hormone replacement therapy [HRT]) play an important role in reducing these negative effects. The North American Menopause Society (NAMS) sought to develop treatment algorithms that could assist the clinician in deciding whether to recommend ERT/HRT to postmenopausal women. Design: NAMS held a closed conference of experts to develop a decision tree that outlined the rational use of ERT/HRT in postmenopausal women on the basis of risks versus benefits. The proceedings of the conference were used to assist the NAMS Board of Trustees in developing this consensus opinion of the Society. Results: On the basis of the conference proceedings, NAMS developed three algorithms for the clinician to use as a tool in deciding whether to recommend ERT/HRT to a woman who is postmenopausal: (1) menopause-related symptoms, (2) cardiovascular risk, and (3) osteoporosis risk. Conclusions: The goal of ERT/HRT is to enhance women's quality of life as well as to reduce the risks of death and disability associated with osteoporosis and coronary heart disease. The decision to initiate ERT/HRT must be individualized according to each woman's needs. This decision tree for ERT/HRT presents a rational approach to decision making on the basis of the principles of care; details of specific therapeutic interventions will change as data from clinical trials are presented. (C) 2000, The North American Menopause Society.

Original languageEnglish
Pages (from-to)76-86
Number of pages11
JournalMenopause
Volume7
Issue number2
StatePublished - 2000
Externally publishedYes

Fingerprint

Decision Trees
Estrogen Replacement Therapy
Consensus
Hormone Replacement Therapy
Menopause
Osteoporosis
Coronary Disease
Quality of Life
Trustees
Progestins
Decision Making
Estrogens
Therapeutics
Clinical Trials
Morbidity
Mortality

All Science Journal Classification (ASJC) codes

  • Obstetrics and Gynecology

Cite this

A decision tree for the use of estrogen replacement therapy or hormone replacement therapy in postmenopausal women : Consensus opinion of The North American Menopause Society. / Utian, Wulf H.; Gass, Margery L S; Sullivan, Jay M.; Stettin, Glen D.; Gallagher, John Christopher G.; Ettinger, Bruce; Lewis, Sandra.

In: Menopause, Vol. 7, No. 2, 2000, p. 76-86.

Research output: Contribution to journalReview article

Utian, Wulf H. ; Gass, Margery L S ; Sullivan, Jay M. ; Stettin, Glen D. ; Gallagher, John Christopher G. ; Ettinger, Bruce ; Lewis, Sandra. / A decision tree for the use of estrogen replacement therapy or hormone replacement therapy in postmenopausal women : Consensus opinion of The North American Menopause Society. In: Menopause. 2000 ; Vol. 7, No. 2. pp. 76-86.
@article{3f9b75b94eae48d7a1d27c55f223d09c,
title = "A decision tree for the use of estrogen replacement therapy or hormone replacement therapy in postmenopausal women: Consensus opinion of The North American Menopause Society",
abstract = "Objective: Menopause is associated with physiologic changes that may have negative effects on quality of life in some women and/or that may increase morbidity and mortality secondary to osteoporosis and/or coronary heart disease. Estrogen replacement therapy (ERT) and combined estrogen/progestogen therapy (hormone replacement therapy [HRT]) play an important role in reducing these negative effects. The North American Menopause Society (NAMS) sought to develop treatment algorithms that could assist the clinician in deciding whether to recommend ERT/HRT to postmenopausal women. Design: NAMS held a closed conference of experts to develop a decision tree that outlined the rational use of ERT/HRT in postmenopausal women on the basis of risks versus benefits. The proceedings of the conference were used to assist the NAMS Board of Trustees in developing this consensus opinion of the Society. Results: On the basis of the conference proceedings, NAMS developed three algorithms for the clinician to use as a tool in deciding whether to recommend ERT/HRT to a woman who is postmenopausal: (1) menopause-related symptoms, (2) cardiovascular risk, and (3) osteoporosis risk. Conclusions: The goal of ERT/HRT is to enhance women's quality of life as well as to reduce the risks of death and disability associated with osteoporosis and coronary heart disease. The decision to initiate ERT/HRT must be individualized according to each woman's needs. This decision tree for ERT/HRT presents a rational approach to decision making on the basis of the principles of care; details of specific therapeutic interventions will change as data from clinical trials are presented. (C) 2000, The North American Menopause Society.",
author = "Utian, {Wulf H.} and Gass, {Margery L S} and Sullivan, {Jay M.} and Stettin, {Glen D.} and Gallagher, {John Christopher G.} and Bruce Ettinger and Sandra Lewis",
year = "2000",
language = "English",
volume = "7",
pages = "76--86",
journal = "Menopause",
issn = "1072-3714",
publisher = "Lippincott Williams and Wilkins",
number = "2",

}

TY - JOUR

T1 - A decision tree for the use of estrogen replacement therapy or hormone replacement therapy in postmenopausal women

T2 - Consensus opinion of The North American Menopause Society

AU - Utian, Wulf H.

AU - Gass, Margery L S

AU - Sullivan, Jay M.

AU - Stettin, Glen D.

AU - Gallagher, John Christopher G.

AU - Ettinger, Bruce

AU - Lewis, Sandra

PY - 2000

Y1 - 2000

N2 - Objective: Menopause is associated with physiologic changes that may have negative effects on quality of life in some women and/or that may increase morbidity and mortality secondary to osteoporosis and/or coronary heart disease. Estrogen replacement therapy (ERT) and combined estrogen/progestogen therapy (hormone replacement therapy [HRT]) play an important role in reducing these negative effects. The North American Menopause Society (NAMS) sought to develop treatment algorithms that could assist the clinician in deciding whether to recommend ERT/HRT to postmenopausal women. Design: NAMS held a closed conference of experts to develop a decision tree that outlined the rational use of ERT/HRT in postmenopausal women on the basis of risks versus benefits. The proceedings of the conference were used to assist the NAMS Board of Trustees in developing this consensus opinion of the Society. Results: On the basis of the conference proceedings, NAMS developed three algorithms for the clinician to use as a tool in deciding whether to recommend ERT/HRT to a woman who is postmenopausal: (1) menopause-related symptoms, (2) cardiovascular risk, and (3) osteoporosis risk. Conclusions: The goal of ERT/HRT is to enhance women's quality of life as well as to reduce the risks of death and disability associated with osteoporosis and coronary heart disease. The decision to initiate ERT/HRT must be individualized according to each woman's needs. This decision tree for ERT/HRT presents a rational approach to decision making on the basis of the principles of care; details of specific therapeutic interventions will change as data from clinical trials are presented. (C) 2000, The North American Menopause Society.

AB - Objective: Menopause is associated with physiologic changes that may have negative effects on quality of life in some women and/or that may increase morbidity and mortality secondary to osteoporosis and/or coronary heart disease. Estrogen replacement therapy (ERT) and combined estrogen/progestogen therapy (hormone replacement therapy [HRT]) play an important role in reducing these negative effects. The North American Menopause Society (NAMS) sought to develop treatment algorithms that could assist the clinician in deciding whether to recommend ERT/HRT to postmenopausal women. Design: NAMS held a closed conference of experts to develop a decision tree that outlined the rational use of ERT/HRT in postmenopausal women on the basis of risks versus benefits. The proceedings of the conference were used to assist the NAMS Board of Trustees in developing this consensus opinion of the Society. Results: On the basis of the conference proceedings, NAMS developed three algorithms for the clinician to use as a tool in deciding whether to recommend ERT/HRT to a woman who is postmenopausal: (1) menopause-related symptoms, (2) cardiovascular risk, and (3) osteoporosis risk. Conclusions: The goal of ERT/HRT is to enhance women's quality of life as well as to reduce the risks of death and disability associated with osteoporosis and coronary heart disease. The decision to initiate ERT/HRT must be individualized according to each woman's needs. This decision tree for ERT/HRT presents a rational approach to decision making on the basis of the principles of care; details of specific therapeutic interventions will change as data from clinical trials are presented. (C) 2000, The North American Menopause Society.

UR - http://www.scopus.com/inward/record.url?scp=0034099334&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0034099334&partnerID=8YFLogxK

M3 - Review article

C2 - 10746889

AN - SCOPUS:0034099334

VL - 7

SP - 76

EP - 86

JO - Menopause

JF - Menopause

SN - 1072-3714

IS - 2

ER -